NY Times online column highlights Cure Alzhemer's Fund's innovative approach to research

NY Times online columnist David Bornstein examines how the Cure Alzheimer's Fund and other organizations have taken a unique approach to research that is intensely goal-directed and collaborative, focusing on the creation of new cures and potential treatment as a process that needs to be managed. Bornstein notes the Fund has worked to bring a sense of urgency to their research that is resulted oriented.

Read more

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.